Per Odin

51 – 60 of 187

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/4ca69e68-ab7c-43c9-af83-34fa2b50cab4?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
5
6
7
8
…
19
next »

2022
Mark Safinamide in the treatment pathway of Parkinson’s Disease : a European Delphi Consensus
Stocchi, Fabrizio ; Antonini, Angelo ; Berg, Daniela ; Bergmans, Bruno ; Jost, Wolfgang ; Katzenschlager, Regina ; Kulisevsky, Jaime ; Odin, Per ^LU ; Valldeoriola, Francesc and Ray Chaudhuri, K. (2022) In npj Parkinson's Disease 8.
- Contribution to journal › Article
Mark Caregiver Burden and Quality of Life in Late Stage Parkinson’s Disease
Rosqvist, Kristina ^LU ; Schrag, Anette and Odin, Per ^LU (2022) In Brain Sciences 12(1).
- Contribution to journal › Article
Mark Non-dopaminergic approaches to the treatment of motor complications in Parkinson's disease
Cenci, M. Angela ^LU ; Skovgård, Katrine ^LU and Odin, Per ^LU (2022) In Neuropharmacology 210.
- Contribution to journal › Scientific review
Mark Quality of life and resource utilization-Swedish data from the Care of Late-Stage Parkinsonism (CLaSP) study
M. Norlin, Jenny ; Hjalte, Frida ; Kruse, Christopher ; Dodel, Richard ; Rosqvist, Kristina ^LU and Odin, Per ^LU (2022) In Acta Neurologica Scandinavica 145(6). p.743-752
- Contribution to journal › Article
Mark Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease
Bergquist, Filip ; Ehrnebo, Mats ; Nyholm, Dag ; Johansson, Anders ; Lundin, Fredrik ; Odin, Per ^LU ; Svenningsson, Per ; Hansson, Fredrik ; Bring, Leif and Eriksson, Elias , et al. (2022) In Neurology 99(10). p.965-976
- Contribution to journal › Article
Mark Insights on Genetic and Environmental Factors in Parkinson's Disease from a Regional Swedish Case-Control Cohort
Brolin, Kajsa ^LU ; Bandres-Ciga, Sara ; Blauwendraat, Cornelis ; Widner, Håkan ^LU ; Odin, Per ^LU ; Hansson, Oskar ^LU ; Puschmann, Andreas ^LU and Swanberg, Maria ^LU (2022) In Journal of Parkinson's Disease 12(1). p.153-171
- Contribution to journal › Article
Mark Diagnostic work up : Laboratory and biomarkers
Cedergren Weber, Gustav and Odin, Per ^LU (2022) In International Review of Neurobiology 162. p.53-96
- Chapter in Book/Report/Conference proceeding › Book chapter
Mark High risk of developing dementia in Parkinson’s disease : a Swedish registry-based study
Åström, Daniel Oudin ^LU ; Simonsen, Jacob ; Raket, Lars Lau ^LU ; Sgarbi, Simona ; Hellsten, Johan ^LU ; Hagell, Peter ^LU ; Norlin, Jenny M. ; Kellerborg, Klas ; Martinez-Martin, Pablo and Odin, Per ^LU (2022) In Scientific Reports 12(1).
- Contribution to journal › Article
Mark Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep : Results from a Meta-Analysis with 24-Month Follow-Up
Chaudhuri, K. Ray ; Antonini, Angelo ; Pahwa, Rajesh ; Odin, Per ^LU ; Titova, Nataliya ; Thakkar, Sandeep ; Snedecor, Sonya J. ; Hegde, Saket ; Alobaidi, Ali and Parra, Juan Carlos , et al. (2022) In Journal of Parkinson's Disease 12(7). p.2071-2083
- Contribution to journal › Scientific review
Mark Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease?
Rota, Silvia ; Urso, Daniele ; van Wamelen, Daniel J. ; Leta, Valentina ; Boura, Iro ; Odin, Per ^LU ; Espay, Alberto J. ; Jenner, Peter and Chaudhuri, K. Ray (2022) In Translational Neurodegeneration 11(1).
- Contribution to journal › Scientific review

« previous
1
…
5
6
7
8
…
19
next »